Literature DB >> 22889786

18F-DOPA PET/CT but not 68Ga-DOTA-TOC PET/CT revealed the underlying cause of ectopic Cushing syndrome.

Camilla Schalin-Jäntti1, Aapo Ahonen, Marko Seppänen.   

Abstract

F-DOPA PET/CT but not Ga-DOTA-TOC PET/CT revealed the cause of ectopic Cushing syndrome in a 61-year-old man. The patient presented with rapid weight gain, swollen legs, and sleep disturbances. Plasma potassium level was 2.7 mM (reference range, 3.3-4.9 mM), 24-hour urinary cortisol level was 13,124 nmol (reference range, 30-144 nmol), and plasma adrenocorticotropin level was 61 ng/L (reference range, <48 g/L). CT demonstrated prominent lymph nodes in the left lung hilus and hyperplastic adrenals but no primary tumor. Ga-DOTA-TOC PET/CT, which is recommended as the first-line PET imaging, was performed, but it was not diagnostic. Imaging with F-DOPA PET/CT revealed the underlying cause.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22889786     DOI: 10.1097/RLU.0b013e318262adc7

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  8 in total

Review 1.  Diagnostic utility of Gallium-68-somatostatin receptor PET/CT in ectopic ACTH-secreting tumors: a systematic literature review and single-center clinical experience.

Authors:  Elena Varlamov; José Miguel Hinojosa-Amaya; Madeleine Stack; Maria Fleseriu
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

2.  Recurrent acute-onset Cushing's syndrome 6 years after removal of a thymic neuroendocrine carcinoma: from ectopic ACTH to CRH.

Authors:  Camilla Schalin-Jäntti; Sylvia L Asa; Johanna Arola; Timo Sane
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

Review 3.  PET imaging in ectopic Cushing syndrome: a systematic review.

Authors:  Prasanna Santhanam; David Taieb; Luca Giovanella; Giorgio Treglia
Journal:  Endocrine       Date:  2015-07-25       Impact factor: 3.633

4.  The Clinical Impact of [68 Ga]-DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone - Secreting Tumours.

Authors:  Taweesak Wannachalee; Adina F Turcu; Irina Bancos; Mouhammed Amir Habra; Anca M Avram; Hubert H Chuang; Steven G Waguespack; Richard J Auchus
Journal:  Clin Endocrinol (Oxf)       Date:  2019-06-12       Impact factor: 3.478

Review 5.  18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.

Authors:  Sona Balogova; Jean-Noël Talbot; Valérie Nataf; Laure Michaud; Virginie Huchet; Khaldoun Kerrou; Françoise Montravers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-16       Impact factor: 9.236

6.  A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing's syndrome.

Authors:  Adriana Albani; Christina M Berr; Felix Beuschlein; Marcus Treitl; Klaus Hallfeldt; Jürgen Honegger; Günter Schnauder; Martin Reincke
Journal:  BMC Endocr Disord       Date:  2019-10-22       Impact factor: 2.763

7.  Comparison of diagnostic efficacy of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT in ectopic adrenocorticotropic hormone syndrome.

Authors:  Bing Zhang; Qiao He; Yali Long; Yuying Zhang; Xiaoyan Wang; Zhifeng Chen; Jianbo Liu; Xiangsong Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

8.  The value of [68Ga]Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors.

Authors:  Fuad Novruzov; Aziz Aliyev; Ming Young S Wan; Rizwan Syed; Elnur Mehdi; Irada Aliyeva; Francesco Giammarile; Jamshed B Bomanji; Irfan Kayani
Journal:  Eur J Hybrid Imaging       Date:  2021-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.